A Melanin-like Nanoenzyme for Acute Lung Injury Therapy via Suppressing Oxidative and Endoplasmic Reticulum Stress Response

• Published in: Pharmaceutics 2021-11, Vol.13 (11), p.1850
• Main Authors: Lou, Xue-Fang, Wang, Chen, Zhang, Ju-Cong, Du, Yong-Zhong, Xu, Xiao-Ling
• Format: Article
• Language: English
• Subjects: 1,8-DHN polymerized nanoparticles; acute lung injury; Endoplasmic reticulum; endoplasmic reticulum stress; Experiments; Laboratory animals; Limited liability companies; melanin-like nanoenzyme; Nanoparticles; Oxidative stress
• ISSN: 1999-4923; 1999-4923
• DOI: 10.3390/pharmaceutics13111850

Nanoenzyme-mediated catalytic activity is emerging as a novel strategy for reactive oxygen species (ROS) scavenging in acute lung injury (ALI) treatment. However, one of the main hurdles for these metal-containing nanoenzymes is their potential toxicity and single therapeutic mechanism. Herein, we uncovered a melanin-like nanoparticles derived from the self-polymerization of 1,8-dihydroxynaphthalene (PDH nanoparticles), showing a significant anti-inflammation therapeutic effect on ALI mice. The prepared PDH nanoparticles rich in phenol groups could not only act as radical scavengers to alleviate oxidative stress but could also chelate calcium overload to suppress the endoplasmic reticulum stress response. As revealed by the therapeutic effect in vivo, PDH nanoparticles significantly prohibited neutrophil infiltration and the secretion of proinflammatory cytokines (TNF-α and IL-6), thus improving the inflammatory cascade in the ALI model. Above all, our work provides an effective anti-inflammatory nanoplatform by using the inherent capability of melanin-like nanoenzymes, proposing the potential application prospects of these melanin-like nanoparticles for acute inflammation-induced injury treatment.